Disclaimer: The information provided in this article is for informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment
MNT had the opportunity to speak with Cheng-Han Chen, MD, a board-certified interventional cardiologist and medical director of the Structural Heart Program at MemorialCare Saddleback Medical Center in Laguna Hills, CA, about this study
Not necessarily, but they should be monitored closely by their healthcare provider
Glucagon-like peptide-1 receptor agonists (GLP-1RAs), initially developed for type 2 diabetes mellitus (T2DM) and weight management, have emerged as a promising treatment due to their anti-inflammatory and immunomodulatory properties
The biosynthetic mechanisms for synthetases use energy from nucleoside triphosphates, whereas synthases do not
Keep Reading Full Microdosing Retatrutide Guide The pharmacokinetic deep-dive with six interactive schedule embeds behind this chart